Home 5 Lab Industry Report 5 FDA-lir 5 FDA Watch: User Fees Dodge a Bullet, a Cancer Drug Approval Breaks New Ground and the Supreme Court Serves Up a Biosims Blockbuster

FDA Watch: User Fees Dodge a Bullet, a Cancer Drug Approval Breaks New Ground and the Supreme Court Serves Up a Biosims Blockbuster

by | Jul 10, 2017

From - Laboratory Industry Report The FDA budget pot continues to boil. In March, the Trump administration proposed a controversial provision to double the medical user fees that diagnostics, medical device and… . . . read more

From - Laboratory Industry Report The FDA budget pot continues to boil. In March, the Trump administration proposed a controversial provision to double the medical user fees that diagnostics, medical device and… . . . read more

This content is Exclusive to Lab Industry Report Subscribers

Subscribe or Log in for Exclusive Access.